Clinical Trial Update: Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer

View source ↗

Summary

Assiut University lists a planned clinical trial evaluating the Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in breast cancer, with recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assiut University | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING